67.1002.84% ( +1.850 )
Delay Closed: Nov 17, 16:08:15Valuation
Current ValuationThe current P/E ratio is -137.00, within the reasonable range, cheaper than 69.73% of the time in the past 1 years, and the industry ranks 7/7, the industry Median 11.62.
-137xP/E
HK$65.25Stock price
HK$-0.48Earnings per share
-137xP/E
Stock priceHK$65.25Earnings per shareHK$-0.48
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -124.64x
- Typical range
- -139.31x–-113.75x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.62x
07142128
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.62x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
02506HKXUNFEIHEALTH | -137.00x | 56.88% | HK$7.89B |
06681HKBRAINAURORA-B | -4.65x | 85.60% | HK$1.73B |
02251HKAIRDOC-B | -10.72x | 60.37% | HK$890.59M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
